Metamizol Normon

Metamizole sodium, the active ingredient in Metamizol Normon, is a pyrazolone presented as an oral tablet for oral use. It treats pain and fever in adult patients and is prescribed when other analgesics are insufficient. GNH USA supplies Metamizol Normon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole sodium is used to manage pain and fever by acting on prostaglandin-mediated pathways. - Pain: provides analgesic relief for moderate to severe pain conditions. - Fever: reduces elevated body temperature in febrile states. - Post‑operative pain: helps control pain after surgical procedures.

Metamizole sodium may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after dosing. - Dizziness: transient light‑headedness. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Hepatotoxicity: significant liver enzyme elevation or injury.

Before prescribing Metamizol Normon, clinicians should consider several safety measures. - Blood count monitoring: assess for agranulocytosis before and during therapy. - Hypersensitivity avoidance: do not use in patients with known pyrazolone allergy. - Renal impairment caution: adjust use in reduced kidney function. - Hepatic disease caution: monitor liver function tests. - Pregnancy and breastfeeding: safety not established; use only if benefits outweigh risks. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Metamizol Normon can interact with other medicines; interactions vary in severity.

Major Interactions (Avoid): - Myelosuppressive agents: increased risk of agranulocytosis. - ACE inhibitors: may enhance hypotensive effect. - Other NSAIDs: heightened gastrointestinal toxicity. - Anticoagulants: increased bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotension. - CYP450 substrates: possible alteration of drug metabolism. - Alcohol: may increase central nervous system depression.